Protective effect ofSpirulina against doxorubicin-induced cardiotoxicity
- 22 December 2005
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 19 (12), 1030-1037
- https://doi.org/10.1002/ptr.1783
Abstract
The generation of reactive oxygen species and mitochondrial dysfunction has been implicated in doxorubicin (DOX)‐induced cardiotoxicity. The aim of the present study was to determine whether Spirulina, a blue‐green algae, could serve as a cardioprotective agent during DOX treatment in a mouse model. Mice were treated with DOX (4 mg/kg bw, intraperitoneally), weekly, for 4 weeks. Spirulina was administered orally for 3 days twice daily, then for 7 weeks along with the four equal injections of DOX. Cardiotoxicity was assessed, at 3 weeks after the end of the DOX‐treatment period, by mortality, volume of ascites, liver congestion, oxidative stress and ultrastructural changes of heart tissue. The DOX‐treated animals showed higher mortality (53%) and more ascites. Myocardial damage, as assessed by ultrastructural changes, showed loss of myofibrils, cytoplasmic vacuolization and mitochondrial swelling. Myocardial superoxide dismutase and glutathione peroxidase activities were decreased and lipid peroxidation was increased. Pretreatment with Spirulina significantly protected the mice from DOX‐induced cardiotoxic effects as evidenced from lower mortality (26%), less ascites, lower levels of lipid peroxidation, normalization of antioxidant enzymes and ultrastructural studies showing minimal damage to the heart. In vitro cytotoxic studies using ovarian cancer cells demonstrated that Spirulina did not compromise the anti‐tumor activity of doxorubicin. These results suggest that Spirulina has a protective effect against cardiotoxicity induced by DOX and it may, therefore, improve the therapeutic index of DOX. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 62 references indexed in Scilit:
- Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injuryChemico-Biological Interactions, 2004
- Modulatory potential ofSpirulina fusiformis on carcinogen metabolizing enzymes in Swiss albino micePhytotherapy Research, 1999
- Hepatoprotective Effect of C-Phycocyanin: Protection for Carbon Tetrachloride andR-(+)-Pulegone-Mediated Hepatotoxicty in RatsBiochemical and Biophysical Research Communications, 1998
- Cardioprotection of rat heart myocytes with amifostine (Ethyol®) and its free thiol, WR-1065, in vitroEuropean Journal of Cancer, 1996
- Preventive effect of Spirulina maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary reportLife Sciences, 1993
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerThe New England Journal of Medicine, 1988
- Tumor necrosis factor in experimental cancer regression with alphatocopherol, beta-carotene, canthaxanthin and algae extractEuropean Journal of Cancer and Clinical Oncology, 1988
- Prevention of experimental oral cancer by extracts of Spirulina‐Dunaliella algaeNutrition and Cancer, 1988
- Adriamycin stimulates NADPH-dependent lipid peroxidation in liver microsomes not only by enhancing the production of O2∸ and H2O2, but also by potentiating the catalytic activity of ferrous ionsToxicology Letters, 1984
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977